# Trade Mark Journal No.2025/025 20 June 2025

## WO0000001857175 (5,42)

Office of origin: United States of America

Date of International Registration:13 March 2025
Date of designation in the UK: 13 March 2025

International priority date claimed: 13 September 2024 (United States of America) (98749246)

Class 5
  Pharmaceutical preparations and therapeutics for the treatment of cardiovascular disease.
Class 42
  Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals.

CeleCor Therapeutics, Inc.

Representative: Christina M. Licursi Wolf, Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210-2206, UNITED STATES OF AMERICA